All HSJ Partners articles
View all stories of the same content type.
-
HSJ PartnersDementia diagnosis: why patients can’t wait for the future
The government’s new vision for dementia diagnosis is ambitious: by 2029, more than 92 per cent of patients could receive a diagnosis within 18 weeks of referral, up from fewer than half today.
-
HSJ PartnersGetting classification right: Why remote monitoring safety depends on using the right level of medical device assurance
Remote monitoring has become an essential component of virtual wards and community-based care. As adoption accelerates, understanding medical-device classification is not a legal technicality, but a matter of clinical safety, governance and system integrity.
-
HSJ PartnersBeyond the attack count: Turning shared decision making into a reality in HAE care
For individuals living with hereditary angioedema (HAE) in the UK, their journey often begins with uncertainty, misdiagnosis and fragmented care.
-
HSJ PartnersClinically led, patient first: Redefining specialist care in dermatology
When lead clinician Andrew Morris reflects on the origins of the Sussex Community Dermatology Service (SCDS), one principle has guided every decision: putting the patient at the centre.
-
HSJ PartnersFostering co-production and tackling racism will build an NHS fit for all
The healthcare system’s current participation and co-production practice with diverse and marginalised communities remains, at best, extremely variable. At its worst, it can be actively harmful in its exclusion of some of the most marginalised voices in society.
-
HSJ PartnersShaping the future of respiratory care together
From addressing critical challenges to shaping innovative solutions: GSK’s medical head, general medicines, UK, Aruni Mulgirigama, shares her perspective on the future of respiratory care
-
HSJ PartnersSpotlighting the hidden challenges facing people living with blood cancer
This content has been developed and funded by Pfizer UK. Cancer is one of the biggest challenges of our lifetime. At Pfizer UK, we are determined to use our voice and position at the forefront of oncology care to help improve outcomes for cancer care and ensure no patient gets ...
-
HSJ PartnersA collaborative, prevention-first approach to tackling chronic kidney disease
This advertorial has been co-written and co-developed as part of the SPOT CKD collaborative working project between Boehringer Ingelheim, Hampshire and Isle of Wight Integrated Care Board, Health Innovation North East and North Cumbria, and the North East and North Cumbria ICB. The article has been funded by Boehringer ...
-
HSJ PartnersTransforming asthma care: Driving evidence-based practice in Bedfordshire, Luton and Milton Keynes ICB
Asthma affects 7.2 million people in the UK, with annual costs to the NHS estimated at £3bn.1,2
-
HSJ PartnersTackling health inequalities in a digital NHS: Making inclusion the national priority
As the NHS accelerates its digital transformation, the ambition is clear: the NHS App is set to become the digital front door for healthcare in England.
-
HSJ PartnersTime to end the postcode lottery in miscarriage care: why we need a national framework now
Irina Spirieva, general manager of Besins Healthcare UK and Ireland, explores the inconsistencies in miscarriage care across the UK and calls for national action to ensure all women receive timely, compassionate, and evidence-based support
-
HSJ PartnersUniversity hospitals key to unlocking UK’s £78bn healthcare innovation potential
Despite clear strengths in basic research and discovery, the UK struggles to translate innovation into clinical outcomes. The University Hospital Association and Boston Consulting Group explore how university hospitals can bridge this gap and deliver transformative benefits to patients, the NHS, and society more broadly.
-
HSJ PartnersBeyond the pilot: How NHS systems are embedding remote monitoring into everyday care
We’re at a turning point in the NHS. After years of pilots, remote monitoring is beginning to take hold at scale.
-
HSJ PartnersEpilepsy care: A system under strain – and the opportunity for change
Epilepsy is the most common long-term neurological condition of childhood in the UK, affecting one in 100 people and costing the NHS up to £2bn annually.1,2 Yet the condition remains underprioritised, despite being treatable and often preventable in its most devastating outcomes.
-
HSJ PartnersSmarter resource management: Why visibility is the NHS’s hidden superpower
With financial pressures mounting, NHS trusts are turning to smarter resource management to improve care and reduce waste. In this HSJ webinar, Royal Papworth and Idox explore how asset tracking and digital visibility are driving trust-wide transformation
-
HSJ PartnersRemote patient monitoring: the NHS’s missing data set for system transformation
Luscii’s Jonathan Lewis shares how live patient data, integrated into shared care and population health, could unlock prevention-first care at scale
-
HSJ PartnersPFI countdown: Securing the NHS estate for tomorrow
With more than 150 NHS PFI contracts expiring by 2051 – most by 2036 – early handback preparation is essential. Anisha Mayor, WSP’s UK head of healthcare, examines how trusts can protect their estates, reduce clinical and financial risks, and transform handback from liability to long-term asset
-
HSJ PartnersHSJ webinar discussed how one trust is turning staff into AI leaders
On-demand now available Faced with diverse and fast-growing communities alongside cost and efficiency pressures, many NHS trusts are trying to do more with less while still delivering outstanding patient outcomes. Sponsored by and produced with This HSJ webinar, sponsored by and produced with Multiverse, explored how Barts ...
-
HSJ PartnersCybersecurity in the NHS: Beyond the ransomware headlines
Recent cyber attacks on NHS services underscore the need for trusts to adopt a broader approach to cybersecurity, writes Leigh Jolly, change and information security lead at Konica Minolta Business Solutions (UK) Ltd
-
HSJ PartnersBehind every prescription is a person: reframing medicines optimisation for patient-centric impact in the NHS
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only. Within the NHS, medicines are still too often discussed through the narrow lens of cost. Budgets ...